E-LIB Suche - Ergebnisse für: Mauro, Francesca R.

1

Prevention and management of infectious complications in pa..:

Mikulska, Malgorzata ; Oltolini, Chiara ; Zappulo, Emanuela...
Blood Reviews. 65 (2024) - p. 101180 , 2024

Link: https://doi.org/10.1016/..

2

Severe infections in patients with chronic lymphocytic leuk..:

Mauro, Francesca R ; Frustaci, Anna Maria ; Visentin, Andrea...
Critical Reviews in Oncology/Hematology. , 2024

Link: https://doi.org/10.1016/..

3

High rate of durable responses with undetectable minimal re..:

Mauro, Francesca R. ; Starza, Irene Della ; Messina, Monica...
Haematologica. 108 (2023) 8 - p. 2091-2100 , 2023

Link: https://doi.org/10.3324/..

4

Antibody Response to the SARS-CoV-2 Vaccine and COVID-19 Vu..:

Mauro, Francesca R. ; Giannarelli, Diana ; Galluzzo, Clementina M....
Cancers. 15 (2023) 11 - p. 2993 , 2023

Link: https://doi.org/10.3390/..

5

Pre‐exposure prophylaxis with tixagevimab/cilgavimab in pat..:

Mauro, Francesca R. ; Visentin, Andrea ; Giannarelli, Diana...
British Journal of Haematology. 201 (2023) 3 - p. 564-567 , 2023

Link: https://doi.org/10.1111/..

6

Clonal haematopoiesis as a risk factor for therapy‐related ..:

Voso, Maria‐Teresa ; Pandzic, Tatjana ; Falconi, Giulia...
British Journal of Haematology. 198 (2022) 1 - p. 103-113 , 2022

Link: https://doi.org/10.1111/..

7

Efficacy of idelalisib and rituximab in relapsed/refractory..:

Rigolin, Gian Matteo ; Cavazzini, Francesco ; Piciocchi, Alfonso...
Hematological Oncology. 39 (2021) 3 - p. 326-335 , 2021

Link: https://doi.org/10.1002/..

8

Frontline treatment with the combination obinutuzumab ± chl..:

Herishanu, Yair ; Shaulov, Adir ; Fineman, Riva...
American Journal of Hematology. 95 (2020) 6 - p. 604-611 , 2020

Link: https://doi.org/10.1002/..

9

Redefining the prognostic likelihood of chronic lymphocytic..:

Raponi, Sara ; Ilari, Caterina ; Della Starza, Irene...
British Journal of Haematology. 189 (2020) 5 - p. 853-859 , 2020

Link: https://doi.org/10.1111/..

10

A scoring system to predict the risk of atrial fibrillation..:

Visentin, Andrea ; Deodato, Marina ; Mauro, Francesca R....
Hematological Oncology. 37 (2019) 4 - p. 508-512 , 2019

Link: https://doi.org/10.1002/..

11

Venetoclax in CLL patients who progress after B‐cell Recept..:

Innocenti, Idanna ; Morelli, Francesca ; Autore, Francesco...
British Journal of Haematology. 187 (2019) 1 - p. , 2019

Link: https://doi.org/10.1111/..

12

Unravelling the suboptimal response of TP53‐mutated chronic..:

Guarini, Anna ; Peragine, Nadia ; Messina, Monica...
British Journal of Haematology. 184 (2018) 3 - p. 392-396 , 2018

Link: https://doi.org/10.1111/..

13

In chronic lymphocytic leukaemia with complex karyotype, ma..:

Rigolin, Gian Matteo ; Saccenti, Elena ; Guardalben, Emanuele...
British Journal of Haematology. 181 (2018) 2 - p. 229-233 , 2018

Link: https://doi.org/10.1111/..

14

Biallelic BIRC3 inactivation in chronic lymphocytic leukaem..:

Raponi, Sara ; Del Giudice, Ilaria ; Ilari, Caterina...
British Journal of Haematology. 185 (2018) 1 - p. 156-159 , 2018

Link: https://doi.org/10.1111/..

15

Clinical relevance of hypogammaglobulinemia, clinical and b..:

Mauro, Francesca R. ; Morabito, Fortunato ; Vincelli, Iolanda D....
Leukemia Research. 57 (2017) - p. 65-71 , 2017

Link: https://doi.org/10.1016/..